Effect of the drug â??Immuneâ??- an Ayurveda medication in COVID-19 patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B999- Unspecified infectious disease
- Registration Number
- CTRI/2020/10/028471
- Lead Sponsor
- GR Vishnu Sri
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Mild to Moderate COVID- 19 confirmed patients of age greater than 20 years and upto 58 years and willing to participate with consent
Exclusion Criteria
Who are not willing to participate, with co-morbidities, pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To detect the rise in antibody titre with the drug intake and reduction in inflammatory markers with the drug intake.Timepoint: 2 months
- Secondary Outcome Measures
Name Time Method duration of hospital stayTimepoint: 2 months